| ALK | Anaplastic Lymphoma Kinase |
| CAP | College of American Pathologists |
| CLIA | Clinical Laboratory Improvement Amendments |
| CSF | Cerebrospinal Fluid |
| CSF-TC | Cerebrospinal Fluid Tumor Cells |
| CTC | Circulating Tumor Cells |
| cfDNA | Cell-Free DNA |
| ctDNA | Tumor DNA |
| DAPI | diamindino-2-phenylindole |
| EMT | Epithelial-to-Mesenchymal Transition |
| FISH | Fluorescent in situ hybridization |
| ICC | Immunocytochemistry |
| LP | Lumbar Punctures |
| NGS | Next-Generation Sequencing |
| NSCLC | Non-Small Cell Lung Cancer |
| OS | Overall Survival |
| PFS | Progression-Free Survival |
| SOC | Standard of Care |